Risk of Chronic Kidney Disease in Bronchial Asthma
Recruiting
- Conditions
- Bronchial Asthma
- Interventions
- Diagnostic Test: CBC, CRP ,ESR, ABG , interleukin 6, tumor necrotic factor alpha
- Registration Number
- NCT06472596
- Lead Sponsor
- Sohag University
- Brief Summary
the study aims to determine the frequency and factors associated with chronic kidney disease among asthmatic patients in order to determine persons who are at risk of developing chronic kidney disease and require strict follow up in long run , to evaluate severity of asthma as a potential risk for developing kidney injury , to evaluate relationship between different inflammatory markers with severity of asthma and risk of deneloping chronic kidney disease
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- all children diagnosed as bronchial asthma at sohag university hospitals from age of 2 years to age of 18 years and donot have any associated disease
Exclusion Criteria
- persons who have any chronic illness persons who have any associated disease with bronchial asthma persons who missing clinical and laboratory investigations persons who refusing to give written informed consent for the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description control (healthy persons) CBC, CRP ,ESR, ABG , interleukin 6, tumor necrotic factor alpha healthy persons investigated by same investigations and compare results with asthmatics cases ( asthmatic patients) CBC, CRP ,ESR, ABG , interleukin 6, tumor necrotic factor alpha asthmatics investigated by serum creatinine , GFR calculation , ESR,CRP,ABG,CBC , serum electrolytes , interleukin6, tumor necrotic factor alpha
- Primary Outcome Measures
Name Time Method change in kidney function in asthmatics change in kidney function in asthmatics after diagnosis and start treatment through out the duration of study (an average 1 year ) change in serum creatinine , GFR calculation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Marihan Nazmy Shehata
🇪🇬Sohag, Egypt